BSL News and Updates

Keep track of all breaking news on BSL from all sources in a single place.

Load latest

BSL Ltd.

23 Dec 2022

161.74

-0.36%

Fund pick: Aditya BSL Medium Term Plan

Business Standard

Fund pick of Aditya BSL Medium Term Plan

BSL has lost -39.98% in the last 1 Year

BSL Ltd.

18 Dec 2022

161.74

-0.36%

BSL Ltd to invest 200 cr on setting up cotton spinning unit and modernisation of existing facilities

Business Line

The company is looking to grow its revenues by 20% to touch 500-550 cr by the end of this fiscal

BSL has lost -39.98% in the last 1 Year

BSL Ltd.

30 Aug 2022

161.74

-0.36%

IISc's SARS-CoV-2 virus-like particle may lead to new Covid-19 vaccine

Business Standard

Scientists at the Indian Institute of Science (IISc) Bangalore have developed and tested a novel SARS-CoV-2 virus-like particle that can potentially be developed into a COVID-19 vaccine candidate. To study the SARS-CoV-2 virus, the researchers need to isolate the virus from the samples, create multiple copies of it, and analyse its transmissibility and efficiency at entering living cells. However, working with such a highly infectious virus is dangerous and requires a Bio Safety Level-3 (BSL-3) lab, only a handful of which across the country are equipped to handle such viruses. To address this problem, the team developed and tested a novel virus-like particle (VLP) -- a non-infectious nanoscale molecule that resembles and behaves like the SARS-CoV-2 virus but does not contain its native genetic material. Such VLPs can not only be used to safely study the effect of mutations that may arise in SARS-CoV-2, but can also potentially be developed into a vaccine candidate that can trigger